Dianaty Ali 4

What Happened

• Dianaty Ali, EVP & Chief Product and Technology Officer of MiniMed Group (MMED), was granted two awards totaling 131,312 restricted stock units (RSUs) on 2026-07-01: 94,550 RSUs and 36,762 RSUs. The reported acquisition price for both awards is $0.00 because these are compensation grants, not open-market purchases or sales.

Key Details

• Transaction date: 2026-07-01; Form 4 filed 2026-07-06 (no late-filing flag noted in the filing).
• Award amounts: 94,550 RSUs (F1) and 36,762 RSUs (F4); total = 131,312 RSUs.
• Price: $0.00 per share (award/grant).
• Shares owned after transaction: not specified in this filing (footnote F2 indicates some counts include shares to be issued upon RSU vesting).
• Notable footnotes:
  • F1: 94,550 RSUs vest in approximately equal one-third installments on each of the first three anniversaries of the grant.
  • F4: 36,762 RSUs vest on the third anniversary of the grant (single-date vest).
  • F2: some reported counts include shares to be issued upon vesting of RSUs.
  • F3: filing notes 600 shares were acquired under MMED’s 2026 Employee Stock Purchase Plan on 2026-06-30 (included in certain share totals).
• Filing timeliness: transaction reported on Form 4 filed July 6, 2026; the filing itself does not flag a late report.

Context

• RSUs are compensation awards that convert to actual shares only when they vest and may be forfeited if vesting conditions (e.g., continued employment) are not met. These grants are not an immediate cash purchase or sale and should be viewed as executive compensation rather than a direct market bet.
• The two awards have different vesting schedules (one vests in thirds over three years; the other vests in full at year three), which affects when shares (and any related tax events) will occur.